98%
921
2 minutes
20
Fatty liver disease is a common disease that causes extra fat storage in an individual's liver. Patients with fatty liver disease may progress to cirrhosis and liver failure, further leading to liver cancer. The prevalence of fatty liver disease ranges from 10% to 30% in many countries. In general, detecting fatty liver requires professional neuroimaging modalities or methods such as computed tomography, ultrasound, and medical experts' practical experiences. Considering this point, finding intelligent electronic noninvasive diagnostic approaches are desired at present. Currently, most existing works in the area of computerized noninvasive disease detection often apply one view (modality) or perform multi-view (several modalities) analysis, e.g., face, tongue, and/or sublingual for disease detection. The multi-view data of patients provides more complementary information for diagnosis. However, due to the conditions of data acquisition, interference by human factors, etc., many multi-view data are defective with some missing-view information, making these multi-view data difficult to evaluate. This factor largely affects the performance of classifying disease and the development of fully computerized noninvasive methods. Thus, the purpose of this study is to address the missing view issue among noninvasive disease detection. In this work, a multi-view dataset containing facial, sublingual vein, and tongue images are initially processed to produce corresponding feature for incomplete multi-view disease diagnostic evaluation. Hereby, we propose a novel method, i.e., multi-view completion, to process the incomplete multi-view data in order to complete the missing-view information for classifying fatty liver disease from healthy candidates. In particular, this method can explore the intra-view and inter-view information to produce the missing-view data effectively. Extensive experiments on a collected dataset with 220 fatty liver patients and 220 healthy samples show that our proposed approach achieves better diagnostic results with missing-view completion compared to the original incomplete multi-view data under various classifiers. Related results prove that our method can effectively process the missing-view issue and improve the noninvasive disease detection performance.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.compbiomed.2022.106097 | DOI Listing |
J Anim Sci
September 2025
Centre for Veterinary Systems Transformation and Sustainability, Clinical Department for Farm Animals and Food System Science, University of Veterinary Medicine Vienna, Vienna 1210, Austria.
It is helpful for diagnostic purposes to improve our current knowledge of gut development and serum biochemistry in young piglets. This study investigated serum biochemistry, and gut site-specific patterns of short-chain fatty acids (SCFA) and expression of genes related to barrier function, innate immune response, antioxidative status and sensing of fatty and bile acids in suckling and newly weaned piglets. The experiment consisted of two replicate batches with 10 litters each.
View Article and Find Full Text PDFCell Mol Biol (Noisy-le-grand)
September 2025
Associate Professor, School of Pharmacy, Desh Bhagat University, Mandi Gobindgarh-Punjab 147301, India.
Alcoholic fatty liver disease (AFLD) is a leading cause of chronic liver disease worldwide, contributing to significant morbidity and mortality. Despite its growing prevalence, no FDA-approved pharmacological treatments exist, leaving lifestyle modifications as the primary intervention. AFLD pathogenesis involves a complex interplay of lipid accumulation, oxidative stress, insulin resistance, and inflammation, highlighting the need for innovative therapeutic approaches.
View Article and Find Full Text PDFCell Mol Life Sci
September 2025
Department of Gastroenterology, The Second Hospital of Shandong University, Jinan, China.
Metabolic associated steatohepatitis (MASH) is a severe form of metabolic dysfunction-associated steatotic liver disease (MASLD) characterized by hepatocellular injury, inflammation, and fibrosis. Despite advances in understanding its pathophysiology, the molecular mechanisms driving MASH progression remain unclear. This study investigates the role of long non-coding RNA Linc01271 in MASLD/MASH pathogenesis, ant its involvement in the miR-149-3p/RAB35 axis and PI3K/AKT/mTOR signaling pathway.
View Article and Find Full Text PDFLiver Int
October 2025
The Global NASH Council, Washington, DC, USA.
Background: The Middle East and North Africa (MENA) region is undergoing demographic shifts potentially increasing metabolic dysfunction-associated steatotic liver disease (MASLD) and its complications. We assessed MASLD prevalence and liver disease burden from 2010 to 2021.
Methods: Data from Global Burden of Disease (GBD), United Nations Population Division and NCD Risk Factor Collaboration covering 21 MENA countries were used for annual percent change (APC) trends per Joinpoint regression.
Diabetes Obes Metab
September 2025
Phase I Clinical Trial Research Ward, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, People's Republic of China.
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is an emerging global health concern, and its presence increases the risk of multi-system diseases. This study aimed to investigate the multimorbidity trajectories of chronic diseases in people living with MASLD.
Methods: We identified 137 859 MASLD patients in UK Biobank and used 'propensity score matching' to match an equal number of non-MASLD controls.